The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N02 | Analgesics | |
| 3 | N02C | Antimigraine preparations | |
| 4 | N02CC | Selective serotonin (5HT1) agonists | |
| 5 | N02CC01 | Sumatriptan |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| NASAL - Nasal | 20 mg |
| ORAL - Oral | 50 mg |
| PAREN - Parenteral | 6 mg |
| RECTAL - Rectal | 25 mg |
| Active Ingredient | Description | |
|---|---|---|
| Sumatriptan |
Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| IMIGRAN Nasal spray, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| IMIGRAN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| IMIGRAN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| IMITREX Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| IMITREX Nasal spray | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| IMITREX Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| SUMATRAN Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
